WeSearch
Hub / Tags / Pharma
TAG · #PHARMA

Pharma coverage.

Every story in the WeSearch catalog tagged with #pharma, chronological, with view counts. Subscribe to the per-tag RSS feed to follow this topic in your reader of choice.

60 stories tagged with #pharma, in publish-time order across the WeSearch catalog. Tag pages update as new stories ingest.

⌘ RSS feed for this tag →   or   search "Pharma"

RELATED TAGS
#pharmaceuticals168#healthcare122#health59#pharmacy39#investing21#protest20#clinical-trials16#biotech15#finance13#biotechnology12#politics12#obesity11
DAILY MAVERICK

DIALYSIS DISPUTE : Adcock Ingram unit referred to Competition Tribunal over alleged excessive pricing of dialysis products

The Competition Commission has referred Adcock Ingram Critical Care to the Competition Tribunal for alleged excessive pricing of dialysis products used in the treatment of kidney f…

2 views ·
#healthcare#competition#dialysis
SEEKING ALPHA

Exelixis, Inc. (EXEL) Presents at Jefferies Global Healthcare Conference 2026 Transcript

Exelixis, Inc. (EXEL) Jefferies Global Healthcare Conference 2026 June 3, 2026 11:05 AM EDTCompany ParticipantsAndrew Peters - Senior Vice President of...…

11 views ·
#healthcare#biotech#cancer
SEEKING ALPHA

Telix Pharmaceuticals Limited (TLX) Presents at 46th Annual William Blair Growth Stock Conference - Slideshow

2026-06-03. The following slide deck was published by Telix Pharmaceuticals Limited in conjunction with this event.…

11 views ·
#pharmaceuticals#investing#conference
SEEKING ALPHA

Jazz Pharmaceuticals plc (JAZZ) Presents at Jefferies Global Healthcare Conference 2026 Transcript

Jazz Pharmaceuticals plc (JAZZ) Jefferies Global Healthcare Conference 2026 June 3, 2026 10:30 AM EDTCompany ParticipantsRobert Iannone - Executive VP,...…

9 views ·
#healthcare#biotech#investing
SEEKING ALPHA

Karyopharm Therapeutics Inc. (KPTI) Discusses Phase III SENTRY Trial Results of Selinexor Plus Ruxolitinib in Myelofibrosis Transcript

Karyopharm Therapeutics Inc. (KPTI) Discusses Phase III SENTRY Trial Results of Selinexor Plus Ruxolitinib in Myelofibrosis June 2, 2026 2:00 PM EDTCompany...…

7 views ·
#healthcare#pharmaceuticals#clinical trials
THE HINDU

U.S. FDA issues VAI classification to Granules arm Virginia facility

U.S. FDA classifies Granules Pharmaceuticals' Virginia facility with VAI status, indicating found issues but no immediate regulatory action.…

11 views ·
#health#regulation#pharmaceuticals
SEEKING ALPHA

Aurinia Pharmaceuticals Inc. (AUPH) Shareholder/Analyst Call Prepared Remarks Transcript

Aurinia Pharmaceuticals Inc. (AUPH) Shareholder/Analyst Call June 3, 2026 12:00 PM EDTCompany ParticipantsKevin Tang - Chairman & CEOStephen P.…

8 views ·
#pharmaceuticals#business#finance
THE HINDU

U.S. FDA issues warning letter to Zydus Lifesciences’ Baddi formulation unit

The U.S. Food and Drug Administration (U.S. FDA) has issued a warning letter to Zydus Lifesciences relating to the company’s formulation manufacturing facility in Baddi, Himachal P…

11 views ·
#health#pharmaceuticals#regulation
SEEKING ALPHA

IQVIA Holdings Inc. (IQV) Presents at Jefferies Global Healthcare Conference 2026 Transcript

IQVIA Holdings Inc. (IQV) Jefferies Global Healthcare Conference 2026 June 3, 2026 9:20 AM EDTCompany ParticipantsAri Bousbib - CEO & ChairmanConference...…

9 views ·
#healthcare#technology
INVESTING.COM — NEWS

Form 144 RECURSION PHARMACEUTICALS For: 3 June

5 views ·
WASHINGTON EXAMINER

States already have pharmacy deserts. PBM reforms make it worse

Pharmacy benefit managers have become popular punching bags, primarily because of spread pricing and steering patients to affiliated pharmacies.…

6 views ·
#healthcare#pharmacy#legislation
SEEKING ALPHA

Legend Biotech Jumps 42% On New Data -- Here's What Comes Next

Buy Legend Biotech (LEGN): new Carvykti CARTITUDE-4 data show better survival and <1% Parkinsonism; upside at 3.0x EV/sales—read now.…

5 views ·
#healthcare#biotech#pharmaceuticals
SEEKING ALPHA

Milestone Pharmaceuticals: Taking The Long View

Milestone Pharma (MIST) stays a Hold after Q1 misses and a tough CARDAMYST launch; PSVT pricing, uptake, and payer risk loom.…

4 views ·
#healthcare#pharmaceuticals#earnings
SEEKING ALPHA

Astellas Pharma Inc. (ALPMY) Discusses Corporate Strategic Plan and Vision for Value-Based Healthcare - Slideshow

2026-06-03. The following slide deck was published by Astellas Pharma Inc.…

10 views ·
#healthcare#pharmaceuticals#corporate strategy
THE SYDNEY MORNING HERALD

Contraceptive pill to be made available over the counter

Women will be able to skip the GP and get their contraceptive pill prescribed by a trained pharmacist from Friday.…

32 views ·
#healthcare#contraception#pharmacy
CNBC — TOP

Eli Lilly's top dealmaker says don't be surprised to see more M&A that pushes Lilly into new areas

Eli Lilly's new top dealmaker explains how the company changed its approach to M&A now that it's the most valuable pharmaceutical company in the world.…

20 views ·
#pharmaceuticals#business#acquisition
WASHINGTON EXAMINER

To fight the drug affordability crisis, Trump must crack down on middlemen

Although Trump is taking steps to investigate insurer and PBM practices, it's time for him to crack down on these bad actors once and for all.…

8 views ·
#healthcare#pharmaceuticals#insurance
INVESTING.COM — NEWS

Rhythm Pharmaceuticals stock rating reaffirmed by Citizens

5 views ·
FOX NEWS — LATEST

STEPHEN MOORE: Foreign drug price controls are a hidden tax on Americans

The U.S. pays more for drugs because foreign governments cap prices, creating trade distortions that shift pharmaceutical costs onto Americans.…

8 views ·
#healthcare#pharmaceuticals#trade
SEEKING ALPHA

Roche Holding AG (RHHBY) Presents at American Society of Clinical Oncology (ASCO) Annual Meeting 2026 - Slideshow

2026-06-03. The following slide deck was published by Roche Holding AG in conjunction with this event.…

8 views ·
#oncology#healthcare#pharmaceuticals
CNBC — TOP

Novo Nordisk rolls out Wegovy pill in the UAE — its first market outside the U.S.

Novo's approach to global launches will be guided by patient demand and the strength of healthcare and telehealth infrastructure, the drugmaker said.…

10 views ·
#health#pharmaceuticals#weight loss
FORTUNE

Exclusive: Apoha, a startup building AI models for creating new materials, emerges from stealth with $36 million Series A funding round

VC firm Singular is leading the round for Apoha, which is targeting pharmaceutical and food industry for its 'liquid intelligence.'…

6 views ·
#technology#artificial intelligence#startups
SEEKING ALPHA

Rhythm Pharmaceuticals: The Rare Obesity Platform Is Becoming A Commercial Engine

Rhythm Pharma (RYTM) growth outlook: IMCIVREE approvals for hypothalamic obesity, rapid uptake, catalysts, and pipeline. See more details here.…

6 views ·
#healthcare#pharmaceuticals#obesity
SEEKING ALPHA

MannKind At An Inflection Point: Pediatric Expansion Drives The Story

MannKind’s Afrezza wins FDA approval for pediatric use—unlocking growth and a $300–500M opportunity. Read here for more on MNKD stock.…

10 views ·
#healthcare#pharmaceuticals#diabetes
ALL ARTICLES ON SEEKING ALPHA

Madrigal Pharmaceuticals Could Become The Next Vertex

Madrigal stock buy thesis: Rezdiffra leads MASH as TAM expands; growth for 2–3 years but big competition risks. Click for more on MDGL here.…

13 views ·
#healthcare#pharmaceuticals#investing
INVESTING.COM — NEWS

Form 144 AURINIA PHARMACEUTICALS INC. For: 2 June

7 views ·
STAT

STAT+: Pharmalittle: We’re reading about a Lilly threat to 340B hospitals, Ebola vaccine funding, and more

Lilly gave hospitals participating in a federal drug discount program five days to submit claims data or it will stop the price breaks…

13 views ·
WASHINGTON EXAMINER

Treatment for millions of Americans at stake in ‘skinny label’ Supreme Court case

The Supreme Court will soon decide a case that could upend the balance built into a bipartisan law that has accelerated the launch of generic drugs and saved American patients, emp…

17 views ·
#healthcare#law#pharmaceuticals
STAT

STAT+: Pharmalittle: We’re reading about pancreatic and lung cancer drugs, China biotech growth, and more

Detailed study data for a pancreatic cancer treatment from Revolution Medicines confirmed it increased overall survival, from 13.2 months to 6.7 months…

14 views ·
TECHMEME

Solstice, which uses clinical and compliance documents and AI to accelerate advertising approvals for pharma clients, raised a $21M Series A (Brock E.W. Turner/Axios)

Brock E.W. Turner / Axios : Solstice, which uses clinical and compliance documents and AI to accelerate advertising approvals for pharma clients, raised a $21M Series A — Pharma ma…

16 views ·
YAHOO FINANCE

BioMarin Pharmaceutical Inc. (BMRN) A Stock that Could 10x by 2030 on Pipeline Development

14 views ·
SEEKING ALPHA

Pharvaris N.V. (PHVS) Presents at The 2026 Eastern Allergy Conference - Slideshow

2026-05-30. The following slide deck was published by Pharvaris N.V.…

24 views ·
#pharmaceuticals#allergy#healthcare
ALL ARTICLES ON SEEKING ALPHA

Novartis: H2 Pipeline Readouts Matter, But Valuation Leaves Limited Upside

Q1 results show U.S. generic erosion hitting Entresto/Promacta sales, limited upside at current valuation, and patent-cliff risks.…

17 views ·
#healthcare#pharmaceuticals#finance
INVESTING.COM — NEWS

Form 13G Eloxx Pharmaceuticals For: 29 May

7 views ·
ALL ARTICLES ON SEEKING ALPHA

MannKind Corporation (MNKD) Discusses FDA Approval of Afrezza for Pediatric Diabetes Patients Ages 6 and Older Transcript

MannKind Corporation (MNKD) Discusses FDA Approval of Afrezza for Pediatric Diabetes Patients Ages 6 and Older May 29, 2026 4:30 PM EDTCompany...…

9 views ·
#healthcare#pharmaceuticals#diabetes
GOOGLE NEWS

Actinium Pharmaceuticals Receives Two Patent Allowances Spanning Its Actimab-A and Iomab-ACT Programs - Morningstar

Comprehensive up-to-date news coverage, aggregated from sources all over the world by Google News.…

10 views ·
INVESTING.COM — NEWS

Form 13G BridgeBio Pharma For: 29 May

9 views ·
SEEKING ALPHA

Agios: 'Sell' On Tebapivat Setback LR-MDS And Competitive PK Activator Drug Class

Agios Pharmaceuticals, Inc. a Sell amid tebapivat setback & tougher PK activator competition; see risks, SCD catalysts, and cash runway. Click for an AGIO update.…

8 views ·
#pharmaceuticals#investing#healthcare
INVESTING.COM — NEWS

Form 6K Eupraxia Pharmaceuticals Inc For: 29 May

10 views ·
INVESTING.COM — NEWS

Form 144 VERTEX PHARMACEUTICALS INC / MA For: 29 May

11 views ·
MEDSCAPE

Guselkumab Adds PsA Structural Damage Inhibition to Label

Guselkumab is the only IL-23 inhibitor that has been proven to help stop further structural damage in patients with active psoriatic arthritis.…

12 views ·
#health#pharmaceuticals#fda
SEEKING ALPHA

Vertex Pharmaceuticals Incorporated (VRTX) Presents at Bernstein 42nd Annual Strategic Decisions Conference Transcript

Vertex Pharmaceuticals Incorporated (VRTX) Bernstein 42nd Annual Strategic Decisions Conference May 29, 2026 9:00 AM EDTCompany ParticipantsReshma...…

10 views ·
#biotechnology#pharmaceuticals#healthcare
THE GUARDIAN — UK

Huge haul of weight-loss drugs seized in Northampton country estate

Two men arrested in raid in which 12,000 doses of unlicensed weight-loss medicines were recovered…

9 views ·
#health#law enforcement#pharmaceuticals
SEEKING ALPHA

Atea Pharmaceuticals: I'm Optimistic Ahead Of Critical HPV Catalyst

Atea Pharmaceuticals, Inc. gets a Buy ahead of mid-2026 phase 3 HCV data. Click here to read in detail about the AVIR stock.…

5 views ·
#healthcare#pharmaceuticals#investing
MEDSCAPE

Pharmacists to Prescribe for More Conditions Under New Deal

England&#039;s £340 million pharmacy deal expands independent prescribing but the NPA warns it does little to close a £2.5 billion funding gap.…

16 views ·
#healthcare#pharmacy#government
SEEKING ALPHA

Aspen Pharmacare Holdings Limited (APNHY) Shareholder/Analyst Call Prepared Remarks Transcript

Aspen Pharmacare Holdings Limited (APNHY) Shareholder/Analyst Call May 29, 2026 6:30 AM EDTCompany ParticipantsSibongakonke Nkosi - Investor Relations...…

13 views ·
#business#finance#healthcare
CNBC — TOP

Replimune to resubmit twice-rejected drug for approval after FDA shakeup

Replimune was among the drugmakers that had criticized the FDA for what they called inconsistent guidance around trials and approvals.…

14 views ·
#health#pharmaceuticals#fda
NOT BORING

Weekly Dose of Optimism #195

LDL Gene Therapy, GLP-1s slow Cancer, Supersonic Hermeus, Nanotech, Moon Base + Extra Doses…

8 views ·
#health#gene therapy#cholesterol
INVESTING.COM — NEWS

Cantor Fitzgerald raises ARS Pharmaceuticals stock price target on CSU program potential

6 views ·
INVESTING.COM — NEWS

Hemogenyx Pharmaceuticals grants options, extends warrants

7 views ·
BBC NEWS — UK

More pharmacies in England to prescribe medication from Autumn

The £340m deal will see five common conditions added to the list of things pharmacists can prescribe medication for from this autumn.…

11 views ·
#health#pharmacy#nhs
SOUTH CHINA MORNING POST

China’s Innovent Biologics signs US$10.5 billion Pfizer deal for 12 cancer drug trials

The agreement covers eight early-stage trials from Innovent and four discovery programmes from global giant Pfizer.…

14 views ·
#biopharmaceuticals#cancer#partnership
THE AMERICAN SPECTATOR | USA N

The View’s Joy Behar Is Furious TrumpRX Is Lowering Drug Costs

One day, historians may look back at The View and conclude the program functioned less as political commentary and more as accidental satire. That conclusion became even more plaus…

14 views ·
#healthcare#politics#pharmaceuticals
CNBC — TOP

Innovent Biologics shares rise 10% after pact with Pfizer of up to $10.5 billion

Innovent Biologics rose as much as 10%, after entering a strategic global licensing and collaboration agreement with Pfizer to develop oncology medicines.…

11 views ·
#biotech#pharmaceuticals#oncology
WASHINGTON POST — OPINIONS

Alaska’s good idea to empower pharmacists

10 views ·
SEEKING ALPHA

Eli Lilly and Company (LLY) Presents at Bernstein 42nd Annual Strategic Decisions Conference Transcript

Eli Lilly and Company (LLY) Bernstein 42nd Annual Strategic Decisions Conference May 28, 2026 1:30 PM EDTCompany ParticipantsDaniel Skovronsky - Chief...…

10 views ·
#pharmaceuticals#research#business
INVESTING.COM — NEWS

aTYR Pharma director Paul Schimmel buys $49,630 in common stock

6 views ·
INVESTING.COM — NEWS

Rigel Pharmaceuticals director Ali-Jackson Kamil sells $72,925 in stock

9 views ·
INVESTING.COM — NEWS

Form 144 Eton Pharmaceuticals For: 28 May

12 views ·
SEEKING ALPHA

GSK plc (GSK) Discusses Bepirovirsen Phase III Data and Advances in Hepatitis B Treatment Transcript

GSK plc (GSK) Discusses Bepirovirsen Phase III Data and Advances in Hepatitis B Treatment May 28, 2026 10:00 AM EDTCompany ParticipantsConstantin Fest -...…

8 views ·
#healthcare#pharmaceuticals#clinical trials